within Pharmacolibrary.Drugs.V_Various.V08A_XRayContrastMediaIodinated.V08AB08_Iopentol;
model Iopentol 
   extends Pharmacolibrary.Drugs.ATC.V.V08AB08;

  annotation(Documentation(
    info ="<html><body><p>Iopentol is a non-ionic, low-osmolar iodinated contrast medium previously used for radiographic imaging including computed tomography (CT) scans and angiography. It has been withdrawn or discontinued in many markets and is not in routine clinical use today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on similarities with other non-ionic, low-osmolar iodinated contrast agents (e.g., iohexol) due to lack of direct published PK studies for iopentol in humans.</p><h4>References</h4><ol><li><p>Waaler, A, et al., &amp; Andrew, E (1987). Pharmacokinetics of iopentol in healthy volunteers. <i>Acta radiologica. Supplementum</i> 370 113–117. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2980304/&quot;>https://pubmed.ncbi.nlm.nih.gov/2980304</a></p></li><li><p>Michelet, AA, &amp; Skinnemoen, K (1987). Pharmacokinetics of iopentol in the rat. <i>Acta radiologica. Supplementum</i> 370 101–104. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2980301/&quot;>https://pubmed.ncbi.nlm.nih.gov/2980301</a></p></li><li><p>Andrew, E, et al., &amp; Bach-Gansmo, T (1988). Clinical trial program for iopentol. A new nonionic ratio 3.0 contrast medium with emphasis on clinical phases I and II. <i>Investigative radiology</i> 23 Suppl 1 S189–S192. DOI:<a href=&quot;https://doi.org/10.1097/00004424-198809001-00034&quot;>10.1097/00004424-198809001-00034</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3058629/&quot;>https://pubmed.ncbi.nlm.nih.gov/3058629</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Iopentol;
